title: Editorial commentary: Comparative efficacy of lamivudine and emtricitabine: comparing the results of randomized trials and cohorts.
authors.affiliation: Department of HIV/AIDS, World Health Organization, Geneva, Switzerland.
authors.forename: Nathan
authors.initials: N
authors.lastname: Ford
authors.affiliation: Department of Pharmacology and Therapeutics, Liverpool University, United Kingdom.
authors.forename: Andrew
authors.initials: A
authors.lastname: Hill
authors.affiliation: Department of HIV/AIDS, World Health Organization, Geneva, Switzerland.
authors.forename: Marco
authors.initials: M
authors.lastname: Vitoria
authors.affiliation: Global Evaluative Sciences, Vancouver, Canada Stanford Prevention Research Center, Stanford University School of Medicine, California.
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Mills
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D015497:HIV-1 / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D019562:Viral Load
chemical_list: D044966:Anti-Retroviral Agents